Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 7.26M
March 31, 2026 -7.67M
December 31, 2025 -11.60M
September 30, 2025 11.74M
June 30, 2025 7.959M
March 31, 2025 2.09M
December 31, 2024 -8.897M
September 30, 2024 2.952M
June 30, 2024 1.255M
March 31, 2024 -4.355M
December 31, 2023 -0.388M
September 30, 2023 0.873M
June 30, 2023 7.103M
March 31, 2023 -1.548M
December 31, 2022 2.828M
September 30, 2022 -3.703M
June 30, 2022 1.70M
March 31, 2022 1.208M
Date Value
December 31, 2021 -8.371M
September 30, 2021 -2.952M
June 30, 2021 -0.372M
March 31, 2021 3.715M
December 31, 2020 -7.226M
September 30, 2020 -5.096M
June 30, 2020 -2.853M
March 31, 2020 -7.221M
December 31, 2019 -4.632M
September 30, 2019 -3.247M
June 30, 2019 -4.838M
March 31, 2019 -7.155M
December 31, 2018 -1.828M
September 30, 2018 -2.343M
June 30, 2018 -2.269M
March 31, 2018 -1.941M
December 31, 2017 -1.073M
September 30, 2017 -2.324M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Pfizer Inc. 302.00M
Elite Pharmaceuticals, Inc. 9.261M
Daré Bioscience, Inc. -6.856M
Liquidia Corp. 69.01M
ANI Pharmaceuticals, Inc. 53.62M